Truist Financial’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.57M | Sell |
111,367
-396,951
| -78% | -$23.4M | 0.01% | 733 |
|
|
2025
Q1 | $37.2M | Buy |
508,318
+439,693
| +641% | +$32.2M | 0.06% | 267 |
|
|
2024
Q4 | $5.68M | Buy |
68,625
+563
| +0.8% | +$46.6K | 0.01% | 775 |
|
|
2024
Q3 | $4.87M | Sell |
68,062
-1,842
| -3% | -$132K | 0.01% | 832 |
|
|
2024
Q2 | $4.79M | Sell |
69,904
-15,171
| -18% | -$1.04M | 0.01% | 872 |
|
|
2024
Q1 | $4.56M | Buy |
85,075
+4,291
| +5% | +$230K | 0.01% | 910 |
|
|
2023
Q4 | $4.3M | Buy |
80,784
+7,140
| +10% | +$380K | 0.01% | 920 |
|
|
2023
Q3 | $3.66M | Buy |
73,644
+4,378
| +6% | +$217K | 0.01% | 964 |
|
|
2023
Q2 | $4.12M | Sell |
69,266
-361
| -0.5% | -$21.5K | 0.01% | 907 |
|
|
2023
Q1 | $3.94M | Sell |
69,627
-72,412
| -51% | -$4.1M | 0.01% | 920 |
|
|
2022
Q4 | $10.5M | Buy |
142,039
+35,092
| +33% | +$2.61M | 0.02% | 545 |
|
|
2022
Q3 | $6.37M | Sell |
106,947
-2,528
| -2% | -$151K | 0.01% | 698 |
|
|
2022
Q2 | $6.15M | Buy |
109,475
+29,387
| +37% | +$1.65M | 0.01% | 731 |
|
|
2022
Q1 | $5.91M | Buy |
80,088
+5,621
| +8% | +$415K | 0.01% | 826 |
|
|
2021
Q4 | $5.38M | Buy |
74,467
+361
| +0.5% | +$26.1K | 0.01% | 859 |
|
|
2021
Q3 | $5.68M | Buy |
74,106
+13,267
| +22% | +$1.02M | 0.01% | 826 |
|
|
2021
Q2 | $4.72M | Buy |
60,839
+1,600
| +3% | +$124K | 0.01% | 901 |
|
|
2021
Q1 | $3.65M | Buy |
59,239
+3,130
| +6% | +$193K | 0.01% | 967 |
|
|
2020
Q4 | $3.66M | Buy |
56,109
+587
| +1% | +$38.3K | 0.01% | 929 |
|
|
2020
Q3 | $2.75M | Sell |
55,522
-14,569
| -21% | -$721K | 0.01% | 944 |
|
|
2020
Q2 | $3.34M | Sell |
70,091
-89,180
| -56% | -$4.25M | 0.01% | 830 |
|
|
2020
Q1 | $6.77M | Buy |
159,271
+2,127
| +1% | +$90.5K | 0.02% | 589 |
|
|
2019
Q4 | $9.25M | Buy |
+157,144
| New | +$9.25M | 0.02% | 598 |
|
|
2015
Q3 | – | Sell |
-8,582
| Closed | -$220K | – | 835 |
|
|
2015
Q2 | $220K | Buy |
+8,582
| New | +$220K | 0.01% | 734 |
|